We are delighted to report that the National Anticoagulation Initiative, a key element of the National Initiative for Stroke Reduction in patients with atrial fibrillation, has been shortlisted within the Stroke Care category of the coveted Patient Safety and Care Awards 2014.
Set up in 2013, the National Anticoagulation Initiative aims to decrease strokes in at-risk patients with Atrial Fibrillation (AF). It is a collaboration between thought leaders, innovators, GPs, consultants, cardiologists and haematologists with a shared goal to develop new models of service delivery in the field of stroke prevention. The team has developed a system of care that can be delivered by an integrated, shared care network using a variety of technologies. Professor David Patterson, consultant physician and cardiologist based at Whittington Health and chief executive, Helicon Health, is one of the lead physicians driving the initiative.
David Patterson said:
“The National Initiative For Stroke Reduction in Patients with Atrial Fibrillation is the first project to address the major problem of reducing AF-related strokes via the appropriate, timely, safe and effective use of oral anticoagulation as well as the treatment of the associated co-morbidities of patients with AF. I am proud to be associated with it and delighted that the importance of well-managed anticoagulation is achieving recognition in the Patient Safety & Care Awards shortlist. With the right approach, we can reduce the high economic cost of AF-related stroke, ease the burden on carers, family and society and relieve the associated pressure on health and social services.”
Winners of the Patient Safety and Care Awards 2014 will be announced on Tuesday 15 July at the Grosvenor House Hotel in London. Please click here to find out more about the National Anticoagulation Initiative.
Further information:
David Patterson, chief executive, Helicon Health
David.patterson@heliconhealth.co.uk
Notes to editors
- The National Anticoagulation initiative is funded by INRStar and led by key thought leaders and experts including Sir Muir Gray, Better Value Healthcare Ltd; Dr Andy Hughes, Consultant Haematologist, Brentwood Community Hospital; Dr Greg Fell, Consultant in Public Health, Bradford and Dr Umesh Roy, NHS Leicester.
- David Patterson MD, FRCP, FRSPH is chief executive, Helicon Health and Consultant Physician and Cardiologist based at Whittington Health, North London. He is also Professor of Cardiovascular Medicine at UCL and the University of London and the only cardiovascular clinician in the UK actively involved in delivering a community focused anticoagulant and stroke prevention service.
